Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and approve 1. Audited Financial Results of the Company for the quarter and nine-months ended December 31, 2024 after these results are reviewed by the Audit Committee of the Board. 2. Declaration of Interim Dividend, if any, on the equity share capital of the Company for the Financial Year 2024-25.